Cleared Traditional

K200391 - MPACT Extension

K200391 is the FDA 510(k) clearance for MPACT Extension by Medacta International S.A.. It is a Class 2 Orthopedic device (product code LPH) cleared through the Traditional 510(k) pathway after a 435-day FDA review.

K200391 · Medacta International S.A. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2021
Decision
435d
Days
Class 2
Risk

K200391 is an FDA 510(k) clearance for the MPACT Extension. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Medacta International S.A. (Castel San Pietro (Ch), CH). The FDA issued a Cleared decision on April 28, 2021 after a review of 435 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Orthopedic submissions.

View all Medacta International S.A. devices

Submission Details

510(k) Number K200391 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 2020
Decision Date April 28, 2021
Days to Decision 435 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
313d slower than avg
Panel avg: 122d · This submission: 435d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Medacta USA
Chris Lussier

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 441
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K200391.
Provident II Hip Stems
K201733 · Globus Medical, Inc. · Jul 2021
Bencox THR System
K211866 · Corentec Co., Ltd. · Jul 2021
LINK MobileLink® Acetabular Cup System - Dual Mobility Liners, and Shell/Insert Adapters
K200607 · Waldemar Link GmbH & Co. KG · May 2021
Restoration Anatomic Shell
K210893 · Howmedica Osteonics Corp. A.K.A. Stryker Orthopaedics · Apr 2021
EMPOWR Dual Mobility Metal Liner, EMPOWR Dual Mobility Poly Bearing
K203557 · Encore Medical, L.P. · Feb 2021
ACTIS Duofix Hip Prosthesis
K202472 · DePuy Orthopaedics, Inc. · Oct 2020